Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function

Area of Science:

• Immunology
• Pulmonary Medicine
• Molecular Biology

Background:

• Pulmonary alveolar proteinosis (PAP) is characterized by surfactant accumulation in the lungs.
• PAP often results from impaired alveolar macrophage (AM) function, particularly related to granulocyte macrophage colony-stimulating factor (GM-CSF) signaling.

Purpose of the Study:

• To investigate the role of the transcription repressor Bach2 in AM function and lung homeostasis.
• To determine if Bach2 deficiency leads to PAP-like lung disease.

Main Methods:

• Generation and analysis of Bach2-deficient mice.
• Assessment of AM function, including gene expression and lipid handling.
• Analysis of lung histology and cellular composition (e.g., eosinophils).
• Bone marrow transplantation experiments to confirm the origin of PAP-like lesions.

Main Results:

• Bach2-deficient mice developed PAP-like lung disease with surfactant accumulation.
• Bach2 deficiency in AMs altered lipid handling and gene expression related to chemotaxis, lipid metabolism, and M2 macrophage activation.
• Increased Ym1 and arginase-1 expression, key M2 markers, was observed in Bach2-deficient macrophages.
• Bone marrow transplantation from wild-type donors ameliorated PAP-like lesions, indicating a hematopoietic origin.

Conclusions:

• Bach2 is essential for the functional maturation of AMs and maintaining pulmonary homeostasis.
• The role of Bach2 in AM function and PAP pathogenesis is independent of GM-CSF signaling.
• Bach2 deficiency contributes to lung disease through mechanisms involving M2 macrophage polarization and lipid metabolism.